Please login or sign up to post and edit reviews.
Wildcard: The Next Nano-X, But With Less Risk
Podcast |
Industry Focus
Publisher |
The Motley Fool
Media Type |
audio
Categories Via RSS |
Business
Business News
News
Publication Date |
Jul 14, 2021
Episode Duration |
00:28:03

HyperFine is looking to head to public markets with the lofty goal of disrupting the MRI market with the first FDA-approved portable MRI machine. Join Brian Feroldi and Emily Flippen as they break down HyperFine’s roadshow and unpack this recent SPAC. 

Stocks: HealthCor Catalio Acquisition Corp (HCAQ)

Check out more of our content here:

Podcasts

Youtube

Twitter

Reach us by Email @ IndustryFocus@fool.com

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review